Albuterol Sulfate Inhalation Solution Supply

The contract calls for the supply of 3 mL unit-dose vials, packaged in quantities of 25, containing Albuterol Sulfate Inhalation Solution at a concentration of 0.083 percent, manufactured by Nephron Pharmaceuticals. All products must fully comply with FDA regulations, including accurate labeling, proper packaging, and adherence to specified shelf-life requirements to ensure safety and efficacy. The requirement is structured as a subcontract under the NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is issued by the Department of Defense through its Medical Supply Chain Pharm FSA entity. The solicitation was posted on August 3, 2026, with a firm response deadline of August 10, 2026, and performance is expected to meet defense supply chain standards without geographic restrictions specified. All deliveries must align with federal pharmaceutical procurement protocols and maintain full traceability and compliance throughout the supply chain.